## Abstract Pharmaceutical pregnancy registries document birth defects and other complications reported in pregnancies exposed to specific medications or diseases. A baseline estimate of birth defect prevalence is necessary for comparison. To identify potential teratogenic signals, the pregnancy re
โฆ LIBER โฆ
Regarding the need, or lack thereof, of a comparator group for pregnancy registries
โ Scribed by Rachel Charlton; Marianne Cunnington; John Weil; Corinne de Vries
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 41 KB
- Volume
- 85
- Category
- Article
- ISSN
- 1542-0752
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Measurements of birth defect prevalence:
โ
Angela Scheuerle; Vani X. Vannappagari; Mary K. Miller
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 108 KB
๐ 1 views
Two criteria for the comparison of multi
โ
Dr. M. Horn
๐
Article
๐
1979
๐
John Wiley and Sons
๐
English
โ 521 KB
I n experimental situations examining the effectiveness of p (p z 1) treatmente by comparing treated groups and untreated controls the following question arose: Which experimental arrangement is more appropriate, an arrangement A, using for the p comparisons only one single control, or an arrangemen